Efficacy of VM protein in cirrhotic patients

Investigation of the efficacy of VM protein in reducing ascites in patients with cirrhosis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191227045905N1

Enrollment

Registered

2020-01-01

Start date

2020-01-21

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis. Unspecified cirrhosis of liver

Interventions

Intervention 1: Intervention group: Receiving VM protein sachet three times a day. Intervention 2: Control group: Receiving sachets similar to VM protein sachets three times a day.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Having the diagnosis of cirrhosis

Exclusion criteria

Exclusion criteria: Unwillingness of participation in the study

Design outcomes

Primary

Measure	Time frame
Ascites. Timepoint: One month after taking drugs. Method of measurement: By Ultrasonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAidin Niaki

Shahid Beheshti University of Medical Sciences

niaki@sbmu.ac.ir+98 21 2207 4087

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026